Atlas Trials

Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

Clinical trial NCT05719714 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05719714
Sponsor
Northwestern University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Kidney DiseasesHeart Failure With Preserved Ejection FractionKidney DiseasesHeart Failure
Start date
2024-01-16
Primary completion
2026-09-30
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.